Cargando…
The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse Melanoma
Tumor neoantigens are ideal targets for cancer immunotherapy as they are recognized by host immune system as foreigners and can elicit tumor-specific immune responses. However, existing strategies utilizing RNA or long peptides for the neoantigen vaccines render limited immune responses since only 2...
Autores principales: | Zhang, Yan, Lin, Zhibing, Wan, Yuhua, Cai, Huaman, Deng, Li, Li, Rongxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848027/ https://www.ncbi.nlm.nih.gov/pubmed/31749795 http://dx.doi.org/10.3389/fimmu.2019.02472 |
Ejemplares similares
-
Recombinant Costimulatory Fusion Proteins as Functional Immunomodulators Enhance Antitumor Activity in Murine B16F10 Melanoma
por: Cai, Huaman, et al.
Publicado: (2020) -
A PD-L1-Based Cancer Vaccine Elicits Antitumor Immunity in a Mouse Melanoma Model
por: Lin, Zhibing, et al.
Publicado: (2019) -
Structure Based Prediction of Neoantigen Immunogenicity
por: Riley, Timothy P., et al.
Publicado: (2019) -
Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis
por: Nibeyro, Guadalupe, et al.
Publicado: (2023) -
Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
por: Mariuzza, Roy A., et al.
Publicado: (2023)